Enfusion, Inc. (NYSE:ENFN) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET

Company Participants

Ignatius Njoku – Head-Investor Relations

Oleg Movchan – Interim Chief Executive Officer

Steve Dorton – Chief Financial Officer

Conference Call Participants

Kevin McVeigh – Credit Suisse

James Faucette – Morgan Stanley

Matthew Kikkert – Stifel

Natalie Howe – Bank of America

Dylan Becker – William Blair

Operator

Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion’s Third Quarter 2022 Earnings Conference Call. At this time all lines have been placed on mute to prevent any background noise. [Operator Instructions] As a reminder, this conference call is being recorded.

I would now like to turn the call over to Ignatius Njoku, Head of Investor Relations to begin.

Ignatius Njoku

Thank you. Before we begin, I’d like to remind you that today’s call may contain forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including those set forth in our filings with the SEC and are available in the Investor Relations section in our website. Actual results may differ materially from any forward-looking statements we make today. These forward-looking statements speak only as of today, and the company does not assume any obligation or intent to update them following today’s call, except as required by law.

In addition, today’s call may include non-GAAP measures. These measures should be considered as a supplement to and not as a substitute for GAAP financial measures. Reconciliation to the nearest GAAP measure can be found in today’s earnings press release, which is available on the company’s website.

Hosting today’s call are Oleg Movchan, Enfusion’s Interim Chief Executive Officer; and Steve Dorton, Enfusion’s Chief Financial Officer.

With that, I’d like to turn the call over to Oleg to begin.

Oleg Movchan

Good afternoon, and thank you all for joining us today to discuss our third quarter 2020 results. I’m delighted to be here speaking with you in my role as the company’s Interim CEO, and I’m honored to have received the confidence of the Board to lead Enfusion.

First, let me introduce myself. I’m a founding investor in Enfusion and have been on Enfusion’s Board for over 10 years. I’ve also worked with the company in multiple capacities for more than 13 years. Since my appointment as Interim CEO, I’ve been focused on engaging with our clients and employees for town halls, virtual and in-person meetings. That the more time I spend on the day-to-day operations of the business, the more I appreciate the talent and experience of our team with the strength and depth of Enfusion’s talent pool that gives me the utmost confidence that we’ll continue to deliver innovation in the rapidly changing investment management industry.